Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis.
Stefanie ReisMaria PoppBenedikt SchmidMiriam StegemannMaria-Inti MetzendorfPatrick MeybohmPatrick MeybohmStephanie WeibelPublished in: Journal of clinical medicine (2021)
Certainty of evidence is still low. Moderately affected COVID-19 patients may benefit from therapeutic-dose anticoagulation, but the risk for bleeding is increased.